Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
about
Naturally Occurring Canine Invasive Urinary Bladder Cancer: A Complementary Animal Model to Improve the Success Rate in Human Clinical Trials of New Cancer Drugs.Total cystectomy and subsequent urinary diversion to the prepuce or vagina in dogs with transitional cell carcinoma of the trigone area: a report of 10 cases (2005-2011).Prevention of chemically induced urinary bladder cancers by naproxen: protocols to reduce gastric toxicity in humans do not alter preventive efficacy.Chemotherapy and radiation therapy in 4 dogs with muscle-invasive transitional cell carcinoma of the urinary tract.Randomized phase III trial of piroxicam in combination with mitoxantrone or carboplatin for first-line treatment of urogenital tract transitional cell carcinoma in dogs.An open-label phase 1 dose-escalation clinical trial of a single intravenous administration of gemcitabine in dogs with advanced solid tumors.A Nonselective Cyclooxygenase Inhibitor Enhances the Activity of Vinblastine in a Naturally-Occurring Canine Model of Invasive Urothelial Carcinoma.Clinical features, survival times and COX-1 and COX-2 expression in cats with transitional cell carcinoma of the urinary bladder treated with meloxicam.Vinorelbine rescue therapy for dogs with primary urinary bladder carcinoma.Intensity-modulated and image-guided radiation therapy for treatment of genitourinary carcinomas in dogs.Clinical Evaluation of Tavocept to Decrease Diuresis Time and Volume in Dogs with Bladder Cancer Receiving Cisplatin.Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder.Naturally-Occurring Canine Invasive Urothelial Carcinoma: A Model for Emerging Therapies.Risk factors for treatment-related adverse events in cancer-bearing dogs receiving piroxicam
P2860
Q33593041-1AB15818-9706-4560-A49C-3A2306CC12AEQ34699882-DECCAAED-16A5-420B-8983-893A0AA6A034Q35251869-5D72BF7E-C007-4AAE-96A3-267DD4CFE14DQ36099771-2A76F95A-9D11-4A13-BE39-D6CBE9174E74Q36873717-9473DAF7-E410-46F9-93EE-12554A27E21BQ36975151-E793F00E-8153-4B8A-8C9C-4E67ED3FD6F5Q37053781-4D335CC5-E060-4C5E-A571-C947A7C4C416Q43516906-F03DE0B6-361C-4E58-8AF7-067685CEC17DQ45257248-ABDD7AFD-FEDE-40B3-B848-B796405D96D2Q47718091-64789ECB-C104-47AB-A48D-C88630FD2411Q48109905-4A4BF232-5282-498B-8857-CA2518CA700EQ50882951-E1B009D6-323E-4B66-A429-BF5B9CB5AA84Q55081994-65B377A2-68BE-445B-AB16-B1EE70B95E44Q57541211-63A84F55-4DB1-4625-8F1D-456D73AA2936
P2860
Toxic effects and antitumor response of gemcitabine in combination with piroxicam treatment in dogs with transitional cell carcinoma of the urinary bladder.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Toxic effects and antitumor re ...... cinoma of the urinary bladder.
@ast
Toxic effects and antitumor re ...... cinoma of the urinary bladder.
@en
type
label
Toxic effects and antitumor re ...... cinoma of the urinary bladder.
@ast
Toxic effects and antitumor re ...... cinoma of the urinary bladder.
@en
prefLabel
Toxic effects and antitumor re ...... cinoma of the urinary bladder.
@ast
Toxic effects and antitumor re ...... cinoma of the urinary bladder.
@en
P2093
P356
P1476
Toxic effects and antitumor re ...... rcinoma of the urinary bladder
@en
P2093
Ann K Jeglum
Donna Lindner
Lisa Suslak-Brown
Victoria Nelson
P304
P356
10.2460/JAVMA.238.8.1004
P407
P50
P577
2011-04-01T00:00:00Z